Sommaire

• • ·Editorial Board

    Page :iv

    

• Reviews

  • ·Role of macrophage tissue infiltration in obesity and insulin resistance

    Page :251-260

    V. Bourlier, A. Bouloumie

    Résumé Résumé Plan Plan  
  • ·Intestinal microflora and metabolic diseases

    Page :262-272

    M. Serino, E. Luche, C. Chabo, J. Amar, R. Burcelin

    Résumé Résumé Plan Plan  

• Original Articles

  • ·Urinary albumin excretion in latent autoimmune diabetes in adults (LADA) is more similar to type 2 than type 1 diabetes: Results of the Nord-Trøndelag Health Study 1995–1997

    Page :273-279

    M.A. Radtke, T.I. Lund Nilsen, K. Midthjell, V. Grill

    Résumé Résumé Plan Plan  
  • ·Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function

    Page :280-286

    A. Blanchet Deverly, P. Kangambega, K. Hue, J.-P. Donnet, H. Merault, L. Foucan

    Résumé Résumé Plan Plan  
  • ·Association between angiopoietin-like 6 (ANGPTL6) gene polymorphisms and metabolic syndrome-related phenotypes in the French MONICA Study

    Page :287-292

    V. Legry, L. Goumidi, M. Huyvaert, D. Cottel, J. Ferrières, D. Arveiler, A. Bingham, A. Wagner, J.-B. Ruidavets, P. Ducimetière, P. Amouyel, A. Meirhaeghe

    Résumé Résumé Plan Plan   
  • ·Effects of exposure of human islet beta-cells to normal and high glucose levels with or without gliclazide or glibenclamide

    Page :293-298

    S. Del Guerra, V. D’Aleo, R. Lupi, M. Masini, M. Bugliani, U. Boggi, F. Filipponi, P. Marchetti

    Résumé Résumé Plan Plan  
  • ·Impact of type 2 diabetes mellitus on diffuse inflammatory activation of de novo atheromatous lesions: Implications for systemic inflammation

    Page :299-304

    K. Toutouzas, E. Tsiamis, M. Drakopoulou, A. Synetos, J. Karampelas, M. Riga, C. Tsioufis, D. Tousoulis, E. Stefanadi, C. Vlassis, C. Stefanadis

    Résumé Résumé Plan Plan  
  • ·Combination of cardiorespiratory reflex parameters and heart rate variability power spectrum analysis for early diagnosis of diabetic cardiac autonomic neuropathy

    Page :305-311

    J. Cabezas-Cerrato, A. Gonzalez-Quintela, M. Perez-Rodriguez, A. Calle, E. Faure-Noguera, J.A. Vazquez-Garcia

    Résumé Résumé Plan Plan
  • ·Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay^®) on glycaemic control in type 1 and type 2 diabetes patients

    Page :312-318

    E. Cosson, E. Hamo-Tchatchouang, L. Dufaitre-Patouraux, J.-R. Attali, J. Pariès, P. Schaepelynck-Bélicar

    Résumé Résumé Plan Plan  
  • ·Insulin treatment in IA-2A-positive relatives of type 1 diabetic patients

    Page :319-327

    E. Vandemeulebroucke, F.K. Gorus, K. Decochez, I. Weets, B. Keymeulen, C. De Block, J. Tits, D.G. Pipeleers, C. Mathieu

    Résumé Résumé Plan Plan  

• Short reports

  • ·The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes

    Page :328-331

    I. Kowalska, M.T. Malecki, M. Straczkowski, J. Skupien, M. Karczewska-Kupczewska, A. Nikolajuk, M. Szopa, A. Adamska, N. Wawrusiewicz-Kurylonek, S. Wołczynski, J. Sieradzki, M. Gorska

    Résumé Résumé Plan Plan
  • ·Early decrease in resting energy expenditure with bedtime insulin therapy

    Page :332-335

    C. Fagour, C. Gonzalez, C. Suberville, P. Higueret, C. Rabemanantsoa, M.-C. Beauvieux, H. Gin, V. Rigalleau

    Résumé Résumé Plan Plan  

• Letters to the editor

  • ·Correspondance concerning the article “Safety of recreational scuba diving in type 1 diabetic patients: The Deep Monitoring programme”

    Page :336-337

    N.W. Pollock

    Résumé Résumé Plan Plan
  • ·Answer from authors about the article “Safety of recreational scuba diving in type 1 diabetic patients: The Deep Monitoring programme”

    Page :337

    M. Bonomo, R. Cairoli, G. Verde, L. Morelli, A. Moreo, M. Delle Grottaglie, M.C. Brambilla, E. Meneghini, P. Aghemo, G. Corigliano, A. Marroni